Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML.

Leukemia research - 1 Feb 2008

Popovici Cornel, Charbonnier Aude, Gisserot Olivier, Aguilon Philippe, Rémy Virginie, Olschwang Sylviane, Mozziconacci Marie-Joëlle

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Dasatinib
Share to Fusion Proteins, bcr-abl
Share to Imatinib Mesylate

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Piperazines

Share to Pyrimidines

Share to Thiazoles

Source

Identifiers

PMID: 17412419
DOI: 10.1016/j.leukres.2007.03.001

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML.PMID 17412419Read ↗

CML patient with rare b 2 a 3 (e 13 a 3) variant of BCR-ABL transcript: complete molecular response to imatinib.Semantic proximity Read ↗

E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib.Semantic proximity Read ↗

The first report of chronic myelogenous leukemia with e19a2 micro-BCR/ABL1 presenting with massive myelofibrosis.Semantic proximity Read ↗

[Genetic alterations in AML].Semantic proximity Read ↗

A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.Semantic proximity Read ↗

[Current outlook on mutations of myeloproliferative neoplasms].Semantic proximity Read ↗

Non-Ph variants in CML: guilty drivers?Semantic proximity Read ↗

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.